Asynt Launches Storming New Low Temperature Reaction System
January 20, 2011
DrySyn SnowStorm, Asynt’s cost-effective solution for low temperature reaction chemistry, offers active temperature control without ice formation and the ability to cool and stir up to 12 reaction tubes in parallel. The new DrySyn SnowStorm is ideal for a wide range of applications in chemistry, process development and biology. The ability to cool and stir [...]
Akonni Launches Kit for the Ultra-Rapid Extraction of Human Genomic DNA from Blood
January 20, 2011
Frederick, MD - Akonni Biosystems, a molecular diagnostics company focused on providing rapid and highly scalable solutions for infectious and genetic disease testing, today announced the launch of a TruTip™ kit for extraction of human genomic DNA from fresh or frozen whole blood. The patented TruTip approach uses a nucleic acid binding matrix that easily [...]
Rockland Immunochemicals Announces New GFP Western Blot Kit
January 20, 2011
Rockland Immunochemicals recently announced a new Green Fluorescent Protein (GFP) Western Blot Kit. GFP is routinely used as a reporter of expression. GFP is an ideal biosensor and numerous cell lines have been created that express GFP. Rockland’s GFP Western Blot Kit (catalogue number KCA215) was produced by optimizing Rockland’s Anti-GFP Antibody (catalogue number 600-301-215). [...]
Jay Shendure, M.D. Ph.D. Joins Halo Genomics’ Scientific Advisory Board
January 20, 2011
UPPSALA, Sweden - Halo Genomics AB, a company providing products and services for next generation targeted sequencing, today announced that Dr. Jay Shendure, M.D. Ph.D. has joined the Scientific Advisory Board. “We are excited about having Dr. Shendure as a Scientific Advisor to Halo Genomics. Dr. Shendure’s expertise within the next generation sequencing field will [...]
InVitria Taps Industry Expert to Launch Cell Culture Supplements Product Line
January 20, 2011
Fort Collins, CO - InVitria announced the expansion of its sales and marketing team with the addition of Shawn Smith as Vice President, Sales & Marketing. InVitria has introduced a line of animal component free and defined cell culture media supplements that deliver improved performance for customers in regenerative medicine, bioproduction, life science research and [...]
Chiral Technologies Worldwide Launches New Microsite for Custom Separation Services
January 20, 2011
WEST CHESTER, Pa. - Chiral Technologies Worldwide (CTW), the world’s leading supplier of chirality tools, has launched a new microsite (https://www.chiralseparationservices.com) dedicated to chiral compound separation science. CTW’s custom separation services focus on rapid and cost-effective production of single-enantiomer compounds. The new microsite provides information about CTW’s capabilities and capacities. CTW laboratories are equipped with [...]
OriGene Releases 1500 TrueMAB™ Monoclonal Antibodies
January 20, 2011
Rockville, MD - OriGene Technologies, Inc. has recently achieved a significant milestone in its quest for developing an assay for every human protein through the release of 1,500 mouse monoclonal antibodies under the TrueMAB brand. Each TrueMAB antibody is specifically developed with full-length human proteins produced in HEK293T cells and validated for critical research and [...]
January 20, 2011
SCOTTSDALE, AZ - Health Enhancement Products, Inc. (OTCBB: HEPI) has contracted the analytical services arm of scientific instrument maker Bruker Corporation, based in Billerica, MA, to conduct liquid chromatography, nuclear magnetic resonance and mass spectroscopy on the final remaining isolates identified by the HEPI research team over the last year. This latest news caps months [...]
Agilent Technologies Signs Agreement to Acquire Assets of A2 Technologies
January 19, 2011
SANTA CLARA, Calif., and DANBURY, Conn. - Agilent Technologies Inc. (NYSE: A) and A2 Technologies today announced they have signed a definitive agreement for Agilent to acquire specific assets of A2 Technologies. The acquisition includes substantially all of A2 Technologies' intellectual property, technology, employees and its spectroscopy product portfolio. Subject to customary closing conditions, the [...]
Cellectis’ Meganuclease Technology Used to Efficiently Prevent Viral Infection
January 19, 2011
Paris - Cellectis (Alternext: ALCLS), announced today that scientists from Cellectis therapeutics, the French National Center For Medical Research (CNRS) and Institut de la Vision (Paris) have used its proprietary Meganucleases to successfully prevent infection of cultured cells by a Herpes Simplex virus (HSV-1). The research has just been published online by Molecular Therapy (Mol. [...]
